After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
As Brexit turmoil calms down, let's get back to small cap stocks.
These under-$10 stocks are within range of triggering big breakout trades.
Investors give the side eye to a prediction from Chardan analyst Gbola Amusa that Amicus Therapeutics will be acquired for three times its current market value
Amicus (FOLD) stock is surging this afternoon after a European regulator recommended approving the company's Fabry disease treatment.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.